Restricted accessResearch articleFirst published online 2014-2
Utility of LRF/Pokemon and NOTCH1 Protein Expression in the Distinction Between Nodular Lymphocyte-Predominant Hodgkin Lymphoma and Classical Hodgkin Lymphoma
Classical Hodgkin lymphoma (CHL) and nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) are considered separate entities with different prognosis and treatment. However, morphologic features can be similar and immunohistochemical studies are essential in the distinction; thus, determination of additional biomarkers is of utmost importance. LRF/Pokemon is a proto-oncogene, an interacting partner co-expressed with BCL6 in germinal centers and highly expressed in diffuse large B-cell lymphoma and follicular lymphoma. Conversely, loss of the LRF gene in mouse hematopoietic stem cells results in complete block of early B cell development with concomitant Notch de-repression, indicating its critical role in B versus T cell fate decision at the hematopoietic stem cell stage. For the first time, we show that LRF/Pokemon is predominantly expressed in NLPHL cases as is BCL6 with low to absent NOTCH1 protein expression; while Hodgkin Reed-Sternberg (HRS) cells in CHL show low to absent BCL6 and LRF/Pokemon expression with higher NOTCH1 expression. We illustrate a potential functional interaction between LRF and BCL6 in NLPHL pathogenesis, and differential expression of LRF/Pokemon and NOTCH1 proteins in CHL thus showing differential expression, making for an additional diagnostic marker and therapeutic target.
LeeSUMaedaT. POK/ZBTB proteins: an emerging family of proteins that regulate lymphoid development and function. Immunol Rev. 2012;247:107-119.
2.
LunardiAGuarnerioJWangGMaedaTPandolfiPP. Role of LRF/Pokemon in lineage fate decisions. Blood. 2013;121:2845-2853.
3.
ApostolopoulouKPaterasISEvangelouK. Gene amplification is a relatively frequent event leading to ZBTB7A (Pokemon) overexpression in non-small cell lung cancer. J Pathol. 2007;213:294-302.
4.
JiangLSiuMKWongOG. Overexpression of proto-oncogene FBI-1 activates membrane type 1-matrix metalloproteinase in association with adverse outcome in ovarian cancers. Mol Cancer. 2010;9:318.
5.
MaedaTHobbsRMMerghoubT. Role of the proto-oncogene Pokemon in cellular transformation and ARF repression. Nature. 2005;433:278-285.
6.
MaedaTMerghoubTHobbsRM. Regulation of B versus T lymphoid lineage fate decision by the proto-oncogene LRF. Science. 2007;316:860-866.
7.
LunardiAAlaUEppingMT. A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer. Nat Genet. 2013;45:747-755.
8.
WangGLunardiAZhangJ. Zbtb7a suppresses prostate cancer through repression of a Sox9-dependent pathway for cellular senescence bypass and tumor invasion. Nat Genet. 2013;45:739-746.
9.
DaviesJMHaweNKabarowskiJ. Novel BTB/POZ domain zinc-finger protein, LRF, is a potential target of the LAZ-3/BCL-6 oncogene. Oncogene. 1999;18:365-375.
10.
SakuraiNMaedaMLeeSU. The LRF transcription factor regulates mature B cell development and the germinal center response in mice. J Clin Invest. 2011;121:2583-2598.
11.
HadlandBKHuppertSSKanungoJ. A requirement for Notch1 distinguishes 2 phases of definitive hematopoiesis during development. Blood. 2004;104:3097-3105.
12.
AllmanDAsterJCPearWS. Notch signaling in hematopoiesis and early lymphocyte development. Immunol Rev. 2002;187:75-86.
13.
LitzowMR. Novel therapeutic approaches for acute lymphoblastic leukemia. Hematol Oncol Clin North Am. 2011;25:1303-1317.
14.
FerrandoAA. The role of NOTCH1 signaling in T-ALL. Hematology Am Soc Hematol Educ Program. 2009:353-361.
15.
RossiDRasiSFabbriG. Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia. Blood. 2012;119:521-529.
16.
SteidlCDiepstraALeeT. Gene expression profiling of microdissected Hodgkin Reed-Sternberg cells correlates with treatment outcome in classical Hodgkin lymphoma. Blood. 2012;120:3530-3540.
17.
KanzlerHKuppersRHansmannMLRajewskyK. Hodgkin and Reed-Sternberg cells in Hodgkin’s disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. J Exp Med. 1996;184:1495-1505.
18.
SchmitzRStanelleJHansmannMLKuppersR. Pathogenesis of classical and lymphocyte-predominant Hodgkin lymphoma. Annu Rev Pathol. 2009;4:151-174.
WlodarskaINooyenPMaesB. Frequent occurrence of BCL6 rearrangements in nodular lymphocyte predominance Hodgkin lymphoma but not in classical Hodgkin lymphoma. Blood. 2003;101:706-710.
21.
SchwarzerRDorkenBJundtF. Notch is an essential upstream regulator of NF-κB and is relevant for survival of Hodgkin and Reed-Sternberg cells. Leukemia. 2012;26:806-813.
22.
JundtFAnagnostopoulosIForsterRMathasSSteinHDorkenB. Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma. Blood. 2002;99:3398-3403.
23.
JaffeEHarrisNSteinHVardimanJ. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001.
24.
KopanRIlaganMX. The canonical Notch signaling pathway: unfolding the activation mechanism. Cell. 2009;137:216-233.
25.
PoppemaS.Immunobiology and pathophysiology of Hodgkin lymphomas. Hematology Am Soc Hematol Educ Program. 2005:231-238.
26.
ZhaoBMaruoSCooperA. RNAs induced by Epstein-Barr virus nuclear antigen 2 in lymphoblastoid cell lines. Proc Natl Acad Sci U S A. 2006;103:1900-1905.
27.
SchneiderEMTorlakovicEStuhlerADiehlVTeschHGiebelB. The early transcription factor GATA-2 is expressed in classical Hodgkin’s lymphoma. J Pathol. 2004;204:538-545.
28.
StanelleJDoringCHansmannMLKuppersR. Mechanisms of aberrant GATA3 expression in classical Hodgkin lymphoma and its consequences for the cytokine profile of Hodgkin and Reed/Sternberg cells. Blood. 2010;116:4202-4211.
29.
HeXHeXDaveVP. The zinc finger transcription factor Th-POK regulates CD4 versus CD8 T-cell lineage commitment. Nature. 2005;433:826-833.
30.
GrussHJPintoADuysterJPoppemaSHerrmannF. Hodgkin’s disease: a tumor with disturbed immunological pathways. Immunol Today. 1997;18:156-163.
31.
Teruya-FeldsteinJJaffeESBurdPRKingmaDWSetsudaJETosatoG. Differential chemokine expression in tissues involved by Hodgkin’s disease: direct correlation of eotaxin expression and tissue eosinophilia. Blood. 1999;93:2463-2470.
32.
AtayarCPoppemaSVisserLvan den BergA. Cytokine gene expression profile distinguishes CD4+/CD57+ T cells of the nodular lymphocyte predominance type of Hodgkin’s lymphoma from their tonsillar counterparts. J Pathol. 2006;208:423-430.
33.
RahemtullahAReichardKKPrefferFIHarrisNLHasserjianRP. A double-positive CD4+CD8+ T-cell population is commonly found in nodular lymphocyte predominant Hodgkin lymphoma. Am J Clin Pathol. 2006;126:805-814.
34.
Teruya-FeldsteinJTosatoGJaffeES. The role of chemokines in Hodgkin’s disease. Leuk Lymphoma. 2000;38:363-371.
35.
Zweidler-McKayPAHeYXuL. Notch signaling is a potent inducer of growth arrest and apoptosis in a wide range of B-cell malignancies. Blood. 2005;106:3898-3906.
36.
MarafiotiTPozzobonMHansmannMLDelsolGPileriSAMasonDY. Expression of intracellular signaling molecules in classical and lymphocyte predominance Hodgkin disease. Blood. 2004;103:188-193.
